Literature DB >> 8501325

Listeria monocytogenes-induced interferon-gamma primes the host for production of tumor necrosis factor and interferon-alpha/beta.

E A Havell1.   

Abstract

Mice acquired an enhanced capacity for the production of tumor necrosis factor (TNF) and the interferons (IFN)-alpha, and -beta shortly after intravenous injection of viable Listeria monocytogenes. By the end of the first day of a sublethal infection, mice were primed to produce 100-1000 times more endotoxin-induced serum TNF than is produced by normal mice. Acquisition of the augmented capacity for TNF production was due to L. monocytogenes-induced IFN-gamma. IFN-gamma also primed infected mice for IFN-alpha/beta production. However, in addition to IFN-gamma, other L. monocytogenes-induced mechanisms endowed the host with an enhanced potential for the production of IFN-alpha/beta. Antibody-mediated depletion of various cell types in vivo revealed that CD8+ cells and NK cells are required for the production of L. monocytogenes-induced IFN-gamma during the first day of listeriosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501325     DOI: 10.1093/infdis/167.6.1364

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor.

Authors:  R Kamijo; D Shapiro; J Le; S Huang; M Aguet; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 2.  Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections.

Authors:  Deann T Snyder; Jodi F Hedges; Mark A Jutila
Journal:  J Immunol Res       Date:  2017-04-26       Impact factor: 4.818

3.  The timing of IFNβ production affects early innate responses to Listeria monocytogenes and determines the overall outcome of lethal infection.

Authors:  Francesca Pontiroli; Olivier Dussurget; Ivan Zanoni; Matteo Urbano; Ottavio Beretta; Francesca Granucci; Paola Ricciardi-Castagnoli; Pascale Cossart; Maria Foti
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.